| Ace Inhibitors in Hypertension: A Guide for General Practitioners 1992 Edition Contributor(s): Strube, G. (Author) |
|
 |
ISBN: 0792389638 ISBN-13: 9780792389637 Publisher: Springer OUR PRICE: $52.24 Product Type: Hardcover - Other Formats Published: March 1992 Annotation: This is a valuable, informative review of the use of ACE inhibitors in treating hypertension in general (family) practice. It also serves as a reference for basic information on the pharmacology and mode of action of this relatively novel class of drugs. The general approach reflects the needs of practitioners by emphasizing the pragmatic view. Epidemiology and pharmacology are included in the context of what a general practitioner needs to know for the effective treatment and management of patients at risk from hypertension. The book adopts an easy-to-use layout with the frequent use of tables and charts to present complex information in an easily assimilated way. |
| Additional Information |
| BISAC Categories: - Medical | Cardiology - Medical | Pharmacology - Medical | Family & General Practice |
| Dewey: 610 |
| LCCN: 92177080 |
| Physical Information: 0.24" H x 6.14" W x 9.21" (0.38 lbs) 107 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: ACE inhibitors are one of the most exciting and interesting of recent medical developments. They fit the patho-physiologica1 processes of cardiovascular disease with fascinating precision and are a constant stimulus to the acquisition of greater understanding of the mechanisms involved and of the mode of action of the drugs themselves. There is still much to be learned, especially about the wider effects of the drugs, their precise mode and site of action and about differences between the different preparations. ACE inhibitors are of proven benefit to patients with chronic congestive heart failure and are the latest in the series of drugs used in the treatment of hypertension. Interest in the treatment of hypertension has paralleled the development of hypotensive drugs and the realisation that long-term prognosis could be significantly improved. The treatment of hypertension has progressed in stages following the development of a succession of increasingly effective drugs, each allowing a greater proportion of patients to be treated with fewer and fewer side-effects. First, the ganglion-blocking agents such as hexamethonium and guan- ethidine transformed the outlook for patients with malignant hypertension but proved too unpleasant for routine use in other forms of hypertension. |